Résultats: 4

    Guideline No. 426: Hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management

    J. obstet. gynaecol. Can; 44 (5), 2022
    This guideline was developed by maternity care providers from obstetrics and internal medicine. It reviews the diagnosis, evaluation, and management of the hypertensive disorders of pregnancy (HDPs), the prediction and prevention of preeclampsia, and the postpartum care of women with a previous HDP. Impl...

    WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia

    In 2019, the Executive Guideline Steering Group (GSG) for the World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating the then current WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia. This decision was based on new evidence on the ...

    WHO recommendations for Prevention and treatment of pre-eclampsia and eclampsia

    Hypertensive disorders of pregnancy are an important cause of severe morbidity, longterm disability and death among both mothers and their babies. In Africa and Asia, nearly one tenth of all maternal deaths are associated with hypertensive disorders of pregnancy, whereas one quarter of maternal deaths in...